ASEPTIC MANUFACTURING

CreoSalus, Inc. operates a cGMP facility designed and approved for aseptically manufactured or terminally sterilized parenteral and veterinary injectable pharmaceuticals. Our 20+ years of pharmaceutical manufacturing experienced team will provide development and engineering support from the start of the manufacturing process, including special equipment identification and validation, through product formulation, fill and finish for clinical supplies to post approval commercial manufacturing.

Aseptic filling of drugs is one of the most critical and challenging processes in pharmaceutical manufacturing. Let our experienced team take care of all your parenteral and veterinary drug filling needs. CreoSalus operates a cGMP facility designed and approved for aseptically manufactured or terminally sterilized parenteral and veterinary pharmaceuticals for clinical trials through commercial production.

We specialize in analytical method and manufacturing process research and development with fill batch capacity up to 15,000 units. We welcome small scale projects that may not meet the minimum vial requirement of other larger aseptic fill companies. CreoSalus supports a variety of finished dosage forms and batch sizes ranging from engineering batches to small clinical trials through small scale commercial batches..

Our focus is always the safety of the patient and success of your product. We have in-house Manufacturing, Engineering/Validation, Documentation, Quality Control, and Quality Assurance teams to support this focus within our facility. The facility is also supported by an in-house WFI system, nitrogen system, compressed air system, vial washing and depyrogenation capabilities, autoclave component sterilization, ISO 5 filling lines and QC analytical and microbiology labs. Other capabilities include nitrogen sparge and overlay, argon overlay, filter assembly combinations and integrity testing. We quickly identify product complexities to cost-effectively evaluate your needs and develop a path forward. CreoSalus’s formulation development capabilities are specialized in peptides but can also be applied to small molecules.